HK1005872A1 - 2-(1-piperazinyl)-4- phenycycloalkanopyridine derivativ4es processes for the production thereof and pharmaceutical composition containing the same - Google Patents

2-(1-piperazinyl)-4- phenycycloalkanopyridine derivativ4es processes for the production thereof and pharmaceutical composition containing the same

Info

Publication number
HK1005872A1
HK1005872A1 HK98105004A HK98105004A HK1005872A1 HK 1005872 A1 HK1005872 A1 HK 1005872A1 HK 98105004 A HK98105004 A HK 98105004A HK 98105004 A HK98105004 A HK 98105004A HK 1005872 A1 HK1005872 A1 HK 1005872A1
Authority
HK
Hong Kong
Prior art keywords
alkyl
same
hydrogen atom
piperazinyl
processes
Prior art date
Application number
HK98105004A
Other languages
English (en)
Inventor
Naoki Kai
Katsuhiko Hino
Masato Sakamoto
Tatsuya Kon
Makoto Oka
Kiyoshi Furakawa
Yoshiaki Ochi
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of HK1005872A1 publication Critical patent/HK1005872A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK98105004A 1989-03-03 1998-06-05 2-(1-piperazinyl)-4- phenycycloalkanopyridine derivativ4es processes for the production thereof and pharmaceutical composition containing the same HK1005872A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5254489 1989-03-03

Publications (1)

Publication Number Publication Date
HK1005872A1 true HK1005872A1 (en) 1999-01-29

Family

ID=12917732

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98105004A HK1005872A1 (en) 1989-03-03 1998-06-05 2-(1-piperazinyl)-4- phenycycloalkanopyridine derivativ4es processes for the production thereof and pharmaceutical composition containing the same

Country Status (15)

Country Link
US (1) US5021421A (fr)
EP (1) EP0385237B1 (fr)
KR (1) KR0149649B1 (fr)
AT (1) ATE107922T1 (fr)
AU (1) AU623981B2 (fr)
CA (1) CA2011346C (fr)
DD (1) DD292909A5 (fr)
DE (1) DE69010232T2 (fr)
DK (1) DK0385237T3 (fr)
ES (1) ES2058630T3 (fr)
FI (1) FI94413C (fr)
HK (1) HK1005872A1 (fr)
HU (1) HU204810B (fr)
NO (1) NO177095C (fr)
RU (1) RU2075478C1 (fr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041443A (en) * 1989-02-21 1991-08-20 Dainippon Pharmaceutical Co., Ltd. Medicament for treating cerebral insufficiency diseases, novel 2-(1-piperazinyl)-4-phenylcycloalkanopyrimidine derivatives, and process for the production thereof
PT706796E (pt) * 1993-06-25 2001-06-29 Pola Chem Ind Inc Inibidor de reincorporacao de dopamina
CA2144669A1 (fr) * 1994-03-29 1995-09-30 Kozo Akasaka Derives du biphenyle
US6458789B1 (en) 1999-09-29 2002-10-01 Lion Bioscience Ag 2-aminopyridine derivatives and combinatorial libraries thereof
EP1474401A2 (fr) * 2002-02-05 2004-11-10 Novo Nordisk A/S Nouvelles aryl- et heteroarylpiperazines
CA2602348C (fr) 2005-03-31 2011-03-01 Pfizer Products Inc. Derives de cyclopentapyridine et de tetrahydroquinoline
RU2499795C2 (ru) 2005-07-04 2013-11-27 Хай Пойнт Фармасьютикалс, ЛЛС Антагонисты гистаминовых н3-рецепторов
JP2009537596A (ja) 2006-05-23 2009-10-29 ハイ ポイント ファーマシューティカルズ,リミティド ライアビリティ カンパニー 6−(4−シクロプロピルピペリジン−1−イル)−2’−メチル−[3,4’]−ビピリジン及びその医薬としての使用
WO2007137968A1 (fr) 2006-05-29 2007-12-06 High Point Pharmaceuticals, Llc Benzodioxolylcyclopropylpipérazinylpyridazines
AU2007255724B2 (en) * 2006-06-09 2012-05-10 Dainippon Sumitomo Pharma Co., Ltd. Novel tape preparation
ES2348685T3 (es) * 2006-07-14 2010-12-10 MERCK SHARP & DOHME CORP. Antagonistas diazepan sustituidos de receptores de orexinas.
JP2010510314A (ja) 2006-11-22 2010-04-02 シーサイド セラピューティクス,エルエルシー 精神遅滞、ダウン症候群、脆弱x症候群および自閉症の治療方法
EP2014656A3 (fr) 2007-06-11 2011-08-24 High Point Pharmaceuticals, LLC Nouveaux antagonistes d'hétéocycliques h3
CN101531634B (zh) * 2008-03-10 2013-09-18 北京德众万全医药科技有限公司 一种高纯度的布南色林及其制备方法
CN101530412A (zh) * 2008-03-10 2009-09-16 北京德众万全医药科技有限公司 一种布南色林的药物组合物及其制备方法
CN101747273B (zh) * 2008-12-02 2012-03-07 浙江华海药业股份有限公司 布南色林中间体的制备方法
CN101747272B (zh) * 2008-12-02 2012-11-28 浙江华海药业股份有限公司 布南色林晶型b及其制备方法
CN101766626B (zh) * 2008-12-30 2012-03-07 丽珠医药集团股份有限公司 一种治疗精神分裂症的含布南色林的口服制剂
MX346801B (es) 2009-03-13 2017-03-31 Agios Pharmaceuticals Inc Métodos y composiciones para trastornos relacionados con la proliferación celular.
KR101850813B1 (ko) 2009-06-29 2018-04-20 아지오스 파마슈티컬스 아이엔씨. 치료용 화합물 및 조성물
CN101619039B (zh) * 2009-06-30 2011-04-13 严洁 2-(4-乙基-1-哌嗪基)-4-(4-氟苯基)-5,6,7,8,9,10-六氢芳辛并[b]吡啶及其组合物
ES2594402T3 (es) 2009-10-21 2016-12-20 Agios Pharmaceuticals, Inc. Métodos y composiciones para trastornos relacionados con la proliferación celular
EP2525790B1 (fr) 2009-10-21 2020-05-27 Agios Pharmaceuticals, Inc. Procédés et compositions pour troubles associés à la prolifération cellulaire
BR112013002280A2 (pt) 2010-08-10 2016-05-24 Lupin Ltd composições farmacêuticas orais de liberação controlada compreendendo blonanseina
CN102372673B (zh) * 2010-08-27 2014-04-09 天津市医药集团技术发展有限公司 布南色林结晶及其制备方法
CN102093289B (zh) * 2010-10-29 2012-12-19 常州华生制药有限公司 布南色林中间体的制备方法
CN102030707A (zh) * 2010-11-12 2011-04-27 深圳万和制药有限公司 布南色林中间体的制备方法
ME03074B (fr) 2011-05-03 2019-01-20 Agios Pharmaceuticals Inc Activateurs de la pyruvate kinase destinés à être utilisés en thérapie
CN102827170A (zh) * 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
CN102827073A (zh) 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
HUE038403T2 (hu) 2012-01-06 2018-10-29 Agios Pharmaceuticals Inc Terápiásan alkalmazható vegyületek és alkalmazási módszereik
US9474779B2 (en) 2012-01-19 2016-10-25 Agios Pharmaceuticals, Inc. Therapeutically active compositions and their methods of use
AU2013331626B2 (en) 2012-10-15 2018-08-02 Agios Pharmaceuticals, Inc. Therapeutic compounds and compositions
WO2015003355A2 (fr) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Composés thérapeutiquement actifs et leurs méthodes d'utilisation
US9579324B2 (en) 2013-07-11 2017-02-28 Agios Pharmaceuticals, Inc Therapeutically active compounds and their methods of use
WO2015003360A2 (fr) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Composés thérapeutiquement actifs et leurs méthodes d'utilisation
CA2917671A1 (fr) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Composes de 2,4 ou de 4,6-diaminopyrimidine en tant qu'inhibiteurs des mutants idh2 pour le traitement du cancer
US20150031627A1 (en) 2013-07-25 2015-01-29 Agios Pharmaceuticals, Inc Therapeutically active compounds and their methods of use
US9968595B2 (en) 2014-03-14 2018-05-15 Agios Pharmaceuticals, Inc. Pharmaceutical compositions of therapeutically active compounds
CN104311487B (zh) * 2014-09-22 2016-08-24 江苏正大丰海制药有限公司 一种布南色林晶型及其制备方法
JP7320339B2 (ja) 2015-06-11 2023-08-03 アジオス ファーマシューティカルズ, インコーポレイテッド ピルビン酸キナーゼ活性化因子を使用する方法
KR20180067658A (ko) 2015-10-15 2018-06-20 아지오스 파마슈티컬스 아이엔씨. 악성 종양의 치료를 위한 조합물 요법
MX2018004587A (es) 2015-10-15 2018-08-14 Agios Pharmaceuticals Inc Terapia de combinacion para tratar tumores malignos.
KR20190028109A (ko) 2017-09-08 2019-03-18 연성정밀화학(주) 블로난세린 함유 서방성 제제
CN110575438A (zh) * 2018-06-07 2019-12-17 湖南省湘中制药有限公司 一种布南色林固体分散体的制备及其应用
US10980788B2 (en) 2018-06-08 2021-04-20 Agios Pharmaceuticals, Inc. Therapy for treating malignancies
EP3939954A4 (fr) 2019-03-13 2023-01-04 Otsuka Pharmaceutical Co., Ltd. Procédé d'introduction d'un alkyle inférieur deutéré dans une fraction amine d'un composé contenant une amine secondaire
CN113698347A (zh) * 2020-05-22 2021-11-26 湖南省湘中制药有限公司 一种布南色林工艺杂质f的制备方法
CN113698346A (zh) * 2020-05-22 2021-11-26 湖南省湘中制药有限公司 一种布南色林工艺杂质b的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54128588A (en) * 1978-03-29 1979-10-05 Dainippon Pharmaceut Co Ltd Antidepressive drugs consisting mainly of 2-(1-piperazinyl)- 4-phenylquinoline
DE3124673A1 (de) * 1981-06-24 1983-01-13 Bayer Ag, 5090 Leverkusen Subsituierte 2-amino-pyridinderivate, verfahren zu ihrer herstellung, ihre verwendung in arzneimitteln, sowie deren herstellung
FR2602771B1 (fr) * 1986-08-12 1988-11-04 Rhone Poulenc Sante Nouveaux derives de la benzyl-4 piperazine, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
NO900991D0 (no) 1990-03-01
EP0385237B1 (fr) 1994-06-29
FI901030A0 (fi) 1990-03-01
RU2075478C1 (ru) 1997-03-20
NO900991L (no) 1990-09-04
HU204810B (en) 1992-02-28
HUT53361A (en) 1990-10-28
EP0385237A3 (fr) 1991-03-20
EP0385237A2 (fr) 1990-09-05
FI94413C (fi) 1995-09-11
CA2011346A1 (fr) 1990-09-03
DE69010232D1 (de) 1994-08-04
NO177095C (no) 1995-07-19
DE69010232T2 (de) 1994-12-01
US5021421A (en) 1991-06-04
AU623981B2 (en) 1992-05-28
KR0149649B1 (ko) 1998-10-15
DK0385237T3 (da) 1994-07-25
NO177095B (no) 1995-04-10
KR900014358A (ko) 1990-10-23
ATE107922T1 (de) 1994-07-15
ES2058630T3 (es) 1994-11-01
HU901275D0 (en) 1990-05-28
AU5060490A (en) 1990-09-06
FI94413B (fi) 1995-05-31
CA2011346C (fr) 1999-08-03
DD292909A5 (de) 1991-08-14

Similar Documents

Publication Publication Date Title
HK1005872A1 (en) 2-(1-piperazinyl)-4- phenycycloalkanopyridine derivativ4es processes for the production thereof and pharmaceutical composition containing the same
GB8919434D0 (en) Novel compounds
CS556587A2 (en) Process for preparing aminoderivatives
HU903090D0 (en) Process for the preparation of n-(aryl-oxy-alkyl)-heteroaryl-piperidines and heteroaryl-piperazines and pharmaceutical compositions containing them
MY129970A (en) Hypolipidaemic compounds
AU6129890A (en) Novel compounds
CA2203274A1 (fr) Inhibiteurs de synthese d'apolipoproteines-b
DK0474243T3 (da) 1-methylcarbapenemderivater og fremgangsmåde til fremstilling deraf
HUT50160A (en) Process for production of derivatives of tiophene and medical compositions containing them as active substance
HUT50337A (en) Process for producing benzoxazine derivatives and pharmaceutical compositions comprising the compounds
CS185091A3 (en) Novel n-benzyl-n'-phenyl and phenylalkyl-thioureas
GR3003126T3 (en) Quinolinecarboxylic acid derivatives, a composition comprising the same, process for preparing the same, and the use of the same for the manufacture of medicaments
PT96123A (pt) Metodo de preparacao de um medicamento para tratamento da infeccao do pneumocystis carinii
NO903084D0 (no) Farmasoeytisk anvendbare thiazol-derivater og fremgangsmaate for deres fremstilling.

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20100219